title: [Pulmonary vascular reactivity and the development of edema in the presence of prostaglandin inhibitors in the isolated canine lobe].
abstract: Alveolar hypoxia is the most powerful pulmonary vasoconstrictor. In a previous work, we did not demonstrate significant changes in vascular reactivity and edema formation in an isolated canine lobe model during alveolar hypoxia. The purpose of this study is to define vascular pulmonary reactivity and edema formation after induction of pulmonary vasoconstriction using a prostaglandin inhibitor like tiaprofenic acid and alveolar hypoxia. Six isolated canine pulmonary lobules were instrumented and studied, all of them under two conditions (normoxia FIO2 21% and hypoxia FIO2 5%) four starting in normoxia condition and 2 starting in hypoxia condition.
  
  
  RESULTS
  No significant changes in filtration rate were found, normoxia 0.42 +/- 0.41, hypoxia 0.37 +/- 0.51 ml/min/100 g pulmonary tissue P = NS. The arterial pressure in basal conditions was 25.1 +/- 6.21, and during hypoxia increased to 37 +/- 7.19 cm H2O (Delta 12.0 +/- 1.2 cm H2O). P < 0.001.
  
  
  CONCLUSIONS
  Hypoxia vascular reactivity was significantly increased in tiaprofenic acid pretreated isolated canine lobes, no changes in pulmonary permeability was found nor increased rate in edema formation.
authors.affiliation: Instituto Nacional de Cardiología Ignacio Chávez, INCICH, México, D.F.
authors.forename: A
authors.initials: A
authors.lastname: Palomar Lever
authors.forename: N A
authors.initials: NA
authors.lastname: González Montero
authors.forename: R
authors.initials: R
authors.lastname: Fernández Capistrán
authors.forename: A
authors.initials: A
authors.lastname: Gómez González
authors.forename: R
authors.initials: R
authors.lastname: Harari Ancona
authors.forename: M L
authors.initials: ML
authors.lastname: Martínez Guerra
authors.forename: J
authors.initials: J
authors.lastname: Sandoval Zárate
authors.forename: L
authors.initials: L
authors.lastname: Oppenheimer
mesh_terms: D000818:Animals; D002138:Calibration; D004285:Dogs; D005260:Female; D000860:Hypoxia / Q000503:physiopathology; D066298:In Vitro Techniques; D008297:Male; D011422:Propionates / Q000494:pharmacology*; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000503:physiopathology; D011651:Pulmonary Artery / Q000187:drug effects* / Q000503:physiopathology; D011654:Pulmonary Edema / Q000209:etiology* / Q000503:physiopathology; D011667:Pulmonary Veins / Q000187:drug effects* / Q000503:physiopathology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
chemical_list: D011422:Propionates; D011448:Prostaglandin Antagonists; C021270:tiaprofenic acid